Archive: July 18, 2019

1
Second update of PTAB Trial Practice Guide issued
2
Producers of generic medicines and biosimilars even more supported by EU
3
New Intellectual Property (Dispute Resolution) Bill In Singapore

Second update of PTAB Trial Practice Guide issued

The Patent Trial and Appeal Board (PTAB) issued a second update to its Trial Practice Guide, clarifying a number of logistical matters for practitioners and outlining the PTAB’s expectations and preferences for certain stages of the trial process.

Read More

Producers of generic medicines and biosimilars even more supported by EU

Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC.

Read More

New Intellectual Property (Dispute Resolution) Bill In Singapore

On 8 July 2019, the Intellectual Property (Dispute Resolution) Bill (Bill) was tabled in Parliament, after a public consultation on the draft Bill that was conducted in March 2019 by the Singapore Ministry of Law.

The Bill aims to ensure that the Singapore Intellectual Property (IP) regime continues to support innovative activities in Singapore and positions Singapore as a choice of venue for international IP dispute resolution.

Read More

Copyright © 2019, K&L Gates LLP. All Rights Reserved.